Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Insider Filings - VISWANATHAN RAVI
Last Updated 
27-May-16
Enter symbol:
symbol lookup

 

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

VISWANATHAN RAVI: Declared Holdings
Company/RelationshipReportedShares  Ownership
Adaptimmune Therapeutics plc
Beneficial Owner (10% or more)
NasdaqGS:ADAP
(historical quotes, profile, other insiders)
1-Jan-1659,269,000  Indirect
Ardelyx, Inc.
Beneficial Owner (10% or more)
NasdaqGM:ARDX
(historical quotes, profile, other insiders)
13-Jan-163,803,738  Indirect
Box, Inc. Class A Common Stock
Beneficial Owner (10% or more)
NYSE:BOX
(historical quotes, profile, other insiders)
28-Jan-150  Indirect
CVENT, INC. Common Stock
Beneficial Owner (10% or more)
NYSE:CVT
(historical quotes, profile, other insiders)
25-Nov-143,994,442  Indirect
Dermira, Inc.
Beneficial Owner (10% or more)
NasdaqGS:DERM
(historical quotes, profile, other insiders)
8-Oct-143,502,922  Indirect
Epizyme, Inc.
Beneficial Owner (10% or more)
NasdaqGS:EPZM
(historical quotes, profile, other insiders)
12-Jan-166,260,851  Indirect
INTERLEUKIN GENETICS
Beneficial Owner (10% or more)
Other OTC:ILIU
(historical quotes, profile, other insiders)
23-Dec-1435,298,087  Indirect
Loxo Oncology, Inc.
Beneficial Owner (10% or more)
NasdaqGM:LOXO
(historical quotes, profile, other insiders)
6-Aug-141,789,420  Indirect
Mirna Therapeutics, Inc.
Beneficial Owner (10% or more)
NasdaqGM:MIRN
(historical quotes, profile, other insiders)
6-Oct-152,971,517  Indirect
Roka Bioscience, Inc.
Beneficial Owner (10% or more)
NasdaqGM:ROKA
(historical quotes, profile, other insiders)
22-Jul-143,216,810  Indirect
TRACON Pharmaceuticals, Inc.
Beneficial Owner (10% or more)
NasdaqGM:TCON
(historical quotes, profile, other insiders)
4-Feb-151,888,474  Indirect
TESARO, Inc.
Beneficial Owner (10% or more)
NasdaqGS:TSRO
(historical quotes, profile, other insiders)
18-Mar-1610,275,113  Indirect

Insider & restricted shareholder transactions reported over the last two years
DateSharesStockTransaction
18-Mar-16 *1,420,858TSRO Purchase at $35.19 - $35.19 per share.
(Cost of about $50,000,000)
13-Jan-16 *1,000,000ARDX Purchase at $10 - $10 per share.
(Cost of about $10,000,000)
12-Jan-16 *1,111,111EPZM Purchase at $9 - $9 per share.
(Cost of about $10,000,000)
1-Jan-16 *59,269,000ADAP Statement of Ownership
6-Oct-15 *289,166MIRN Acquisition (Non Open Market) at $0 per share.
6-Oct-15 *857,142MIRN Purchase at $7 - $7 per share.
(Cost of about $6,000,000)
5-Oct-15 *1,825,209MIRN Acquisition (Non Open Market)
15-Jun-15 *553TSRO Sale at $54.96 - $54.96 per share.
(Proceeds of about $30,000)
12-Jun-15 *336TSRO Sale at $54.53 - $54.53 per share.
(Proceeds of about $18,000)
5-Jun-15 *2,803,738ARDX Statement of Ownership
1-Jun-15 *1,010,000TSRO Disposition (Non Open Market) at $0 per share.
1-Jun-15 *10,336TSRO Acquisition (Non Open Market) at $0 per share.
4-Feb-15 *1,388,474TCON Acquisition (Non Open Market)
4-Feb-15 *500,000TCON Purchase at $10 - $10 per share.
(Cost of about $5,000,000)
28-Jan-15 *2,091,457BOX Disposition (Non Open Market)
28-Jan-15 *1,928,677BOX Acquisition (Non Open Market)
22-Jan-15 *162,780BOX Statement of Ownership
23-Dec-14 *19,868,965ILIU Purchase at $0.10 - $0.1 per share.
(Cost of about $1,987,000)
25-Nov-14 *1,010,000CVT Disposition (Non Open Market) at $0 per share.
25-Nov-14 *10,336CVT Acquisition (Non Open Market) at $0 per share.
8-Oct-14 *69,112DERM Purchase at $16 - $16 per share.
(Cost of about $1,106,000)
8-Oct-14 *3,416,569DERM Acquisition (Non Open Market) at $0 per share.
2-Oct-14 *17,241DERM Statement of Ownership
18-Aug-14 *336CVT Sale at $26.04 - $26.04 per share.
(Proceeds of about $8,749)
18-Aug-14 *433EPZM Sale at $35.56 - $35.56 per share.
(Proceeds of about $15,000)
14-Aug-14 *1,302,900EPZM Disposition (Non Open Market) at $0 per share.
14-Aug-14 *13,333EPZM Acquisition (Non Open Market) at $0 per share.
14-Aug-14 *10,336CVT Acquisition (Non Open Market) at $0 per share.
14-Aug-14 *1,010,000CVT Disposition (Non Open Market) at $0 per share.
6-Aug-14 *230,769LOXO Purchase at $13 - $13 per share.
(Cost of about $3,000,000)
6-Aug-14 *1,558,651LOXO Acquisition (Non Open Market)
22-Jul-14 *2,828,743ROKA Acquisition (Non Open Market)
22-Jul-14 *383,333ROKA Purchase at $12 - $12 per share.
(Cost of about $4,600,000)
16-Jul-14 *4,734ROKA Statement of Ownership
    * Indicates that some (or all) shares are held indirectly (e.g. in a trust, by a spouse, etc.)



EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search


Copyright © 2016 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Data and information are provided by EDGAR Online, Inc. for informational purposes only and not intended for trading purposes. Yahoo!, EDGAR Online, Inc. shall have no liability for the accuracy of the information furnished or for delays, omissions or opinions expressed therein. You may not use the information for any illegal purpose or furnish the information to any person, firm, or branch office for commercial re-use or re-sale.

Questions or Comments?